Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
n-3 fatty acids for septic encephalopathy and cognitive dysfunction in sepsis
NCT00772096Phase 4Completed
- Sponsor
- University Hospital Basel
- Start
- Oct 2008
- Primary completion
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of omega-3-acid triglycerides in sepsis-associated encephalopathy (SAE), cognitive dysfunction, sponsored by University Hospital Basel. Started Oct 2008; status: completed.
02
Drugs
omega-3-acid triglycerides
03
Conditions
sepsis-associated encephalopathy (SAE)cognitive dysfunction
Beyond the preview
Go deeper on NCT00772096.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00772096.